Gene · 2030
Papers2,306
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,306
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| (n, m) Distribution of Single-Walled Carbon Nanotubes Grown from a Non-Magnetic Palladium Catalyst. | Molecules | 2023 | 36985423 | PubTator, text mining | PubMed |
| Pharmacology-Based Prediction of the Targets and Mechanisms for Icariin against Myocardial Infarction. | Medicina (Kaunas) | 2023 | 36984421 | PubTator, text mining | PubMed |
| Influence of Single-Nucleotide Polymorphisms on Clinical Outcomes of Capecitabine-Based Chemotherapy in Colorectal Cancer Patients: A Systematic Review. | Cancers (Basel) | 2023 | 36980706 | PubTator, text mining | PubMed |
| Structural basis of the substrate recognition and inhibition mechanism of Plasmodium falciparum nucleoside transporter PfENT1. | Nat Commun | 2023 | 36977719 | PubTator, text mining | PubMed |
| The molecular mechanism of cardiac injury in SARS-CoV-2 infection: Focus on mitochondrial dysfunction. | J Infect Public Health | 2023 | 36958170 | PubTator, text mining | PubMed |
Molecular targeting of the UDP-glucuronosyltransferase enzymes in high-eukaryotic translation initiation factor 4E refractory/relapsed acute myeloid leukemia patients: a randomized phase II trial of vismodegib, ribavirin with or without decitabine. | Haematologica | 2023 | 36951168 | PubTator, text mining | PubMed |
| The cell cycle and cell size influence the rates of global cellular translation and transcription in fission yeast. | EMBO J | 2023 | 36951016 | PubTator, text mining | PubMed |
| HAP1, a new revolutionary cell model for gene editing using CRISPR-Cas9. | Front Cell Dev Biol | 2023 | 36936678 | PubTator, text mining | PubMed |
| Circadian rhythm in restless legs syndrome. | Front Neurol | 2023 | 36908590 | PubTator, text mining | PubMed |
| The Pleiotropic Role of Extracellular ATP in Myocardial Remodelling. | Molecules | 2023 | 36903347 | PubTator, text mining | PubMed |
| Isogenic Cell Lines Derived from Specific Organ Metastases Exhibit Divergent Cytogenomic Aberrations. | Cancers (Basel) | 2023 | 36900209 | PubTator, text mining | PubMed |
| Comprehensive multimodal management of borderline resectable pancreatic cancer: Current status and progress. | World J Gastrointest Surg | 2023 | 36896309 | PubTator, text mining | PubMed |
| Modeling drug-induced liver injury and screening for anti-hepatofibrotic compounds using human PSC-derived organoids. | Cell Regen | 2023 | 36864321 | PubTator, text mining | PubMed |
| A Systematic Role of Metabolomics, Metabolic Pathways, and Chemical Metabolism in Lung Cancer. | Vaccines (Basel) | 2023 | 36851259 | PubTator, text mining | PubMed |
| Prognostic 7-SLC-Gene Signature Identified via Weighted Gene Co-Expression Network Analysis for Patients with Hepatocellular Carcinoma. | J Oncol | 2023 | 36844876 | PubTator, text mining | PubMed |
| The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy. | Pharmaceutics | 2023 | 36839686 | PubTator, text mining | PubMed |
| Determining RNA Natural Modifications and Nucleoside Analog-Labeled Sites by a Chemical/Enzyme-Induced Base Mutation Principle. | Molecules | 2023 | 36838506 | PubTator, text mining | PubMed |
| Solute Carrier Family 29A1 Mediates In Vitro Resistance to Azacitidine in Acute Myeloid Leukemia Cell Lines. | Int J Mol Sci | 2023 | 36834962 | PubTator, text mining | PubMed |
| Genome-Wide Association Analysis Identified Variants Associated with Body Measurement and Reproduction Traits in Shaziling Pigs. | Genes (Basel) | 2023 | 36833449 | PubTator, text mining | PubMed |
| Antitumor Potential of Antiepileptic Drugs in Human Glioblastoma: Pharmacological Targets and Clinical Benefits. | Biomedicines | 2023 | 36831117 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2030/papers?page=13